アメリカのインターベンショナル心臓医療機器市場(~2021)

◆英語タイトル:United States Interventional Cardiology Market Outlook to 2021
◆商品コード:GDMECC1433DB
◆発行会社(調査会社):GlobalData
◆発行日:2016年2月1日
◆ページ数:172
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

United States Interventional Cardiology Market Outlook to 2021
Summary

GlobalData’s new report, “United States Interventional Cardiology Market Outlook to 2021″, provides key market data on the United States Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments – Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Interventional Cardiology market segments – Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Interventional Cardiology market.
- Global corporate-level profiles of key companies operating within the United States Interventional Cardiology market.
- Key players covered include Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cordis Corporation, Terumo Corporation and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Interventional Cardiology Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Interventional Cardiology Market, United States 14
3.1 Interventional Cardiology Market, United States, Revenue ($m), 2007-2014 14
3.2 Interventional Cardiology Market, United States, Revenue ($m), 2014-2021 16
3.2.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2007-2014 18
3.2.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2007-2014 20
3.2.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2007-2014 22
3.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2007-2014 24
3.2.5 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2007-2014 26
3.2.6 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2014-2021 28
3.2.7 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2014-2021 30
3.2.8 Coronary Stents Market, United States, Revenue ($m), by Segment, 2014-2021 32
3.2.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2014-2021 34
3.2.10 PTCA Balloons Market, United States, Revenue ($m), by Segment, 2014-2021 36
3.3 Interventional Cardiology Market, United States, Volume (Units), 2007-2014 38
3.4 Interventional Cardiology Market, United States, Volume (Units), 2014-2021 40
3.4.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2007-2014 42
3.4.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2007-2014 44
3.4.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2007-2014 46
3.4.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2007-2014 48
3.4.5 PTCA Balloons Market, United States, Volume (Units), by Segment, 2007-2014 50
3.4.6 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2014-2021 52
3.4.7 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2014-2021 54
3.4.8 Coronary Stents Market, United States, Volume (Units), by Segment, 2014-2021 56
3.4.9 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2014-2021 58
3.4.10 PTCA Balloons Market, United States, Volume (Units), by Segment, 2014-2021 60
3.5 Interventional Cardiology Market, United States, Average Price ($), 2007-2021 62
3.6 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2013-2014 66
3.7 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2014 67
4 Overview of Key Companies in United States, Interventional Cardiology Market 69
4.1 Boston Scientific Corporation 69
4.1.1 Company Overview 69
4.2 Abbott Laboratories 69
4.2.1 Company Overview 69
4.3 Medtronic plc 69
4.3.1 Company Overview 69
4.4 St. Jude Medical, Inc. 70
4.4.1 Company Overview 70
4.5 Asahi Intecc Co., Ltd. 70
4.5.1 Company Overview 70
4.6 Volcano Corporation 70
4.6.1 Company Overview 70
4.7 Cook Medical Incorporated 70
4.7.1 Company Overview 70
4.8 Terumo Corporation 71
4.8.1 Company Overview 71
4.9 Edwards Lifesciences Corporation 71
4.9.1 Company Overview 71
4.10 Cordis Corporation 71
4.10.1 Company Overview 71
4.11 Cardinal Health, Inc. 72
4.11.1 Company Overview 72
5 Interventional Cardiology Market Pipeline Products 73
6 Financial Deals Landscape 75
6.1 Acquisition 75
6.1.1 AtriCure Acquires nContact 75
6.1.2 TE Connectivity Acquires AdvancedCath for USD190 Million 77
6.2 Debt Offerings 78
6.2.1 Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020 78
6.3 Equity Offerings 80
6.3.1 Hansen Medical to Raise USD35 Million in Private Placement of Shares and Warrants 80
6.3.2 Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 82
6.4 Venture Financing 84
6.4.1 Saphena Medical Raises USD1.27 Million in Venture Financing 84
6.4.2 Cardiac Dimensions Raises Additional USD15.2 Million in Venture Financing 85
6.4.3 Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round 87
7 Recent Developments 88
7.1 Corporate Communications 88
7.1.1 Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors 88
7.1.2 Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer 88
7.1.3 Nov 09, 2015: AngioDynamics Announces Resignation of CFO and Appointment of Interim CFO 89
7.1.4 Nov 02, 2015: Data from Merz Aesthetics’ Post-Market Clinical Study of Xeomin(incobotulinumtoxinA) vs. Botox (onabotulinumtoxinA) for Glabellar Facial Lines Published in Dermatologic Surgery 89
7.1.5 Oct 08, 2015: SANUWAVE Health Releases dermaPACE Clinical Trial Top Line Data and Preliminary Data Analysis Results 91
7.1.6 Sep 09, 2015: LED Medical Diagnostics’ VELscope Vx Receives Regulatory Approval for Distribution in China 93
7.1.7 Aug 10, 2015: Transgenomic Establishes Clinical-Commercial Advisory Board to Help Optimize Use of Multiplexed ICE COLD-PCR in Oncology 94
7.1.8 Jul 15, 2015: Boston Scientific Elects Donna A. James To Board Of Directors 95
7.1.9 Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group 96
7.1.10 Jun 09, 2015: Transgenomic Expands Board of Directors and Executive Team 97
7.1.11 May 27, 2015: Boston Scientific Names Prof. John Mark Morgan as Senior Medical Director, Rhythm Management 98
7.1.12 May 26, 2015: IMRIS and Two Subsidiaries File for Chapter 11 Protection 98
7.1.13 Apr 13, 2015: Onxeo announces 6th positive DSMB recommendation for Livatag ReLive study in HCC 99
7.1.14 Mar 06, 2015: SurModics Announces New Board Chair 100
7.1.15 Mar 03, 2015: Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 101
7.1.16 Feb 24, 2015: Cardiva Medical Announces Appointment of John Russell, President and Chief Executive Officer 101
7.1.17 Feb 05, 2015: SurModics Announces Gerald B. Fischer’s Retirement from Board of Directors 102
7.2 Financial Announcements 102
7.2.1 Dec 18, 2015: BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack 102
7.2.2 Dec 18, 2015: Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping 104
7.2.3 Nov 12, 2015: Transgenomic Reports Third Quarter 2015 Financial Results 105
7.2.4 Nov 10, 2015: SurModics Reports Fourth Quarter Fiscal 2015 Results 108
7.2.5 Nov 05, 2015: Hansen Medical Reports Third Quarter 2015 Results and Business Update 109
7.2.6 Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015 111
7.2.7 Oct 08, 2015: AngioDynamics to Present at the Jefferies 2015 Healthcare Conference 112
7.2.8 Oct 01, 2015: FDA Panel To Discuss On TransMedics PMA Application For OCS Heart Device 114
7.2.9 Sep 30, 2015: MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S. 115
7.2.10 Sep 09, 2015: Tandem Diabetes Care Announces FDA Approval of t:slim G4 Insulin Pump with CGM Integration 116
7.2.11 Aug 13, 2015: Transgenomic Reports Second Quarter 2015 Financial Results 118
7.2.12 Aug 06, 2015: Hansen Medical Reports Second Quarter 2015 Results and Business Update 121
7.2.13 Aug 05, 2015: SurModics Reports Third Quarter Fiscal 2015 Results 122
7.2.14 Jul 23, 2015: Boston Scientific Announces Results For Second Quarter 2015 124
7.2.15 Jul 16, 2015: AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results 125
7.2.16 Jul 01, 2015: Aesculap Implant Systems Introduces the Modulift Vertebral Body Replacement System 126
7.2.17 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 128
7.2.18 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results 132
7.2.19 May 14, 2015: Transgenomic Reports First Quarter 2015 Financial Results 135
7.2.20 May 07, 2015: Hansen Medical Reports First Quarter 2015 Results and Business Update 136
7.2.21 Apr 30, 2015: SurModics Reports Second Quarter Fiscal 2015 Results 138
7.2.22 Apr 28, 2015: Boston Scientific Announces Results for First Quarter 2015 139
7.2.23 Apr 15, 2015: Transgenomic Provides Financial and Business Update 140
7.2.24 Apr 09, 2015: AngioDynamics Reports 2015 Third Quarter Financial Results 142
7.2.25 Mar 04, 2015: IMRIS Reports Fourth Quarter and Annual 2014 Financial Results 144
7.2.26 Feb 23, 2015: Hansen Medical Reports Fourth Quarter and Full-Year 2014 Results 145
7.2.27 Feb 04, 2015: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2014 148
7.2.28 Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results 149
7.2.29 Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine 151
7.3 Legal And Regulatory 151
7.3.1 Dec 03, 2015: FDA Lifts Warning Letters on AngioDynamics’ Facilities 151
7.3.2 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury’s Notice 2015-79 152
7.3.3 Nov 17, 2015: AngioDynamics Announces Resolution of FDA Warning Letter 152
7.3.4 Aug 20, 2015: Harvard’s Wyss Institute improves its sepsis therapeutic device 152
7.3.5 Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas 154
7.3.6 Feb 17, 2015: Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation 155
7.3.7 Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to “SubQ Stimulation” Procedures 155
7.3.8 Feb 04, 2015: Federal judge approves consent decree with Maquet Holding 156
7.4 Other Significant Developments 157
7.4.1 Jan 08, 2016: SurModics Provides Updated 2016 Guidance 157
7.4.2 Oct 15, 2015: New Swedish clinic treats first cancer patients with proton therapy 158
7.4.3 May 06, 2015: Boston Scientific Coyol, Costa Rica Facility Earns Shingo Award For Excellence In Manufacturing 160
7.4.4 May 01, 2015: Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 160
7.4.5 Feb 10, 2015: Premier awards specialty urology purchasing contract to Cook Medical 162
7.4.6 Feb 03, 2015: Boston Scientific Maple Grove Operations Named A 2014 “Best Plants” Winner 162
7.4.7 Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants 163
8 Appendix 164
8.1 Research Methodology 165
8.1.1 Coverage 165
8.1.2 Secondary Research 165
8.1.3 Primary Research 166
8.1.4 Market Modeling and Forecasting 167
8.1.5 Company Share Analysis 170
8.1.6 Distribution Share Analysis 171
8.2 Expert Panel 172
8.3 GlobalData Consulting 172
8.4 Contact Us 172
8.5 Disclaimer 172

1.1 List of Tables
Table 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 15
Table 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 17
Table 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 19
Table 4: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 21
Table 5: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 23
Table 6: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 25
Table 7: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 27
Table 8: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Table 9: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Table 10: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 33
Table 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Table 12: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Table 13: Interventional Cardiology Market, United States, Volume (Units), Historic, 2007-2014 39
Table 14: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2014-2021 41
Table 15: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2007-2014 43
Table 16: Cardiac Catheters Market, United States, Volume (Units), Historic, 2007-2014 45
Table 17: Coronary Stents Market, United States, Volume (Units), Historic, 2007-2014 47
Table 18: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2007-2014 49
Table 19: PTCA Balloons Market, United States, Volume (Units), Historic, 2007-2014 51
Table 20: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2014-2021 53
Table 21: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2014-2021 55
Table 22: Coronary Stents Market, United States, Volume (Units), Forecast, 2014-2021 57
Table 23: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2014-2021 59
Table 24: PTCA Balloons Market, United States, Volume (Units), Forecast, 2014-2021 61
Table 25: Interventional Cardiology Market, United States, Average Price ($) Historic, 2007-2014 62
Table 26: Interventional Cardiology Market, United States, Average Price ($), Forecast, 2014-2021 64
Table 27: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 66
Table 28: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2014 68
Table 29: Interventional Cardiology Market Pipeline Products 73
Table 30: AtriCure Acquires nContact 75
Table 31: TE Connectivity Acquires AdvancedCath for USD190 Million 77
Table 32: Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020 78
Table 33: Hansen Medical to Raise USD35 Million in Private Placement of Shares and Warrants 80
Table 34: Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 82
Table 35: Saphena Medical Raises USD1.27 Million in Venture Financing 84
Table 36: Cardiac Dimensions Raises Additional USD15.2 Million in Venture Financing 85
Table 37: Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round 87
Table 38: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 167

1.2 List of Figures
Figure 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 14
Figure 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 16
Figure 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 18
Figure 4: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 20
Figure 5: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 22
Figure 6: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 24
Figure 7: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 26
Figure 8: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Figure 9: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Figure 10: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Figure 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Figure 12: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Figure 13: Interventional Cardiology Market, United States, Volume (Units), Historic, 2007-2014 38
Figure 14: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2014-2021 40
Figure 15: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2007-2014 42
Figure 16: Cardiac Catheters Market, United States, Volume (Units), Historic, 2007-2014 44
Figure 17: Coronary Stents Market, United States, Volume (Units), Historic, 2007-2014 46
Figure 18: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2007-2014 48
Figure 19: PTCA Balloons Market, United States, Volume (Units), Historic, 2007-2014 50
Figure 20: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2014-2021 52
Figure 21: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2014-2021 54
Figure 22: Coronary Stents Market, United States, Volume (Units), Forecast, 2014-2021 56
Figure 23: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2014-2021 58
Figure 24: PTCA Balloons Market, United States, Volume (Units), Forecast, 2014-2021 60
Figure 25: Interventional Cardiology Market, United States, Company Share (%) 2014 67
Figure 26: GlobalData Epidemiology-Based Forecasting Model 169
Figure 27: GlobalData Capital Equipment-Based Forecasting Model 170
Figure 28: Primary Interviews by Participant Type (%) 171

【掲載企業】

Boston Scientific Corporation
Abbott Laboratories
Medtronic plc
St. Jude Medical, Inc.
Asahi Intecc Co., Ltd.
Volcano Corporation
Cook Medical Incorporated
Terumo Corporation
Edwards Lifesciences Corporation
Cordis Corporation
Cardinal Health, Inc.

★調査レポート[アメリカのインターベンショナル心臓医療機器市場(~2021)]販売に関する免責事項
★調査レポート[アメリカのインターベンショナル心臓医療機器市場(~2021)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆